Skip to content
PubMed This is a summary of 12 peer-reviewed journal articles Updated
Nephrology

How HHRH Affects the Body: Bone and Kidney Symptoms

At a Glance

HHRH can cause low blood phosphate that weakens bones and high urine calcium that affects the kidneys. Children may develop rickets and growth problems, adults osteomalacia, and patients may develop kidney stones or nephrocalcinosis; some carriers also have high urine calcium or kidney stones.

Because Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) is so rare, its symptoms can vary widely from person to person—even among siblings with the exact same genetic mutations [1]. The disease primarily affects two systems: the skeleton (bones) and the renal system (kidneys).

Clinical expression is highly variable. In one large literature review of genetically confirmed cases, some patients presented with symptoms in both systems, while others presented with primarily bone issues or primarily kidney issues. A small percentage of individuals with two pathogenic variants may even appear outwardly asymptomatic, highlighting the need for thorough biochemical and imaging evaluation [2].

Skeletal Symptoms: The Impact on Bones

The skeletal symptoms of HHRH are caused by low phosphate levels in the blood (hypophosphatemia). Without enough phosphate, the body cannot properly “mineralize” or harden new bone tissue.

In Children (Rickets):

  • Leg Bowing: This is often the most visible sign. As a child begins to walk, their soft bones may curve outward (genu varum) or inward (genu valgum or “knock-knees”) [3][4].
  • Growth Issues: Children with HHRH often have short stature or a slowing of their growth rate compared to other children their age [5].
  • Bone Pain and Weakness: Patients might experience dull, aching pain in their legs or hips, or develop a “waddling” gait due to muscle weakness [2][3].
  • Widened Joints: Unusual widening may be seen at the wrists or ankles, which are areas of active bone growth [5].

In Adults (Osteomalacia):

  • Bone Softening: If undiagnosed until adulthood, or if inadequately treated, the condition is called osteomalacia. It can cause persistent bone pain and a higher risk of fractures [6].
  • Low Bone Density: Adults may develop osteopenia or osteoporosis (thinning of the bones) earlier than expected [7][8].

Renal Symptoms: The Impact on Kidneys

While the bones suffer from a lack of minerals, the kidneys must filter an excess of calcium. This hypercalciuria is a major risk factor for kidney complications.

  • Hypercalciuria (High Urine Calcium): This is found in nearly all patients with the full disease [9].
  • Nephrolithiasis (Kidney Stones): Many people with HHRH will develop kidney stones, which can cause intense pain, blood in the urine, and infections [9].
  • Nephrocalcinosis: This occurs when calcium deposits form directly inside the kidney tissue itself. In some specialized study cohorts, a majority of patients showed some level of renal calcification, though individual risk varies based on age, treatment, and genetics [7].
  • Chronic Kidney Disease (CKD): While less common, the long-term buildup of calcium and recurrent stones can lead to permanent kidney scarring and a decline in kidney function over time [10].

The “Carrier” Experience: What Parents Should Know

HHRH is a recessive disease, meaning most parents are “carriers” (heterozygous) who have only one mutated copy of the SLC34A3 gene. For a long time, carriers were thought to be completely unaffected. However, research has shown that carriers can experience their own, usually milder, set of symptoms [11][8].

In family-based studies, a significant subset of carriers (roughly a third in some cohorts) demonstrated higher-than-normal levels of calcium in their urine. This means that:

  • Kidney Stones: Carriers appear to have an increased risk of developing kidney stones compared to the general population [9][7].
  • Bone Health: Some carriers may have slightly lower bone mineral density, though they rarely develop the severe bowing seen in children with the full disease [7][12].

Because of these risks, it is important for parents and siblings who are carriers to undergo individualized screening. A nephrologist or genetic counselor can help determine if a carrier needs urine calcium screening or bone density monitoring, based on their personal symptoms and family history [7].

Common questions in this guide

What bone symptoms can HHRH cause in children and adults?
In children, low phosphate can cause rickets, with bowed or knock-kneed legs, slowed growth, short stature, bone pain, muscle weakness, a waddling gait, or widened wrists and ankles. In adults, untreated or inadequately treated HHRH can cause osteomalacia, or soft bones, persistent bone pain, low bone density, and a higher risk of fractures.
Why does HHRH increase the risk of kidney stones?
HHRH can cause hypercalciuria, meaning too much calcium in the urine. This can promote kidney stones and calcium deposits in kidney tissue, called nephrocalcinosis; recurrent stones and calcium buildup can less commonly contribute to chronic kidney disease.
Can HHRH affect the bones and kidneys differently from one person to another?
Yes. Some people have mainly bone findings, others mainly kidney findings, and some have problems in both systems; symptoms can differ even among siblings with the same genetic variants. A small number of people with two pathogenic variants may have no obvious symptoms, so clinical evaluation and testing can still be important.
Can someone who carries one SLC34A3 variant have HHRH-related symptoms?
Yes. Some heterozygous carriers have higher urine calcium, an increased risk of kidney stones, or slightly lower bone mineral density, although they usually do not develop the severe leg bowing seen in children with HHRH. Screening should be individualized based on symptoms and family history.
What monitoring may be needed for a person with HHRH or carrier status?
Clinicians may monitor growth and bone alignment in children, urine calcium, and the kidneys for silent stones or nephrocalcinosis with imaging such as ultrasound. Depending on personal findings and family history, they may also consider bone density monitoring and repeat imaging, with the schedule individualized for each person.

Get notified when new evidence is published on Hereditary hypophosphatemic rickets with hypercalciuria.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (12)
  1. 1

    SLC34A3 GENE MUTATION AS A RARE CAUSE OF HYPOPHOSPHATEMIA IN TWO SIBLINGS.

    Karakilic-Ozturan E, Ozturk AP, Oney C, et al.

    Acta endocrinologica (Bucharest, Romania : 2005) 2022; (18(3)):387-391 doi:10.4183/aeb.2022.387.

    PMID: 36699160
  2. 2

    Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature.

    Christensen S, Tebben PJ, Sas D, Creo AL

    Hormone research in paediatrics 2021; (94(9-10)):374-389 doi:10.1159/000520299.

    PMID: 34666334
  3. 3

    Novel Variant of SLC34A3 in a Compound Heterozygous Brazilian Girl with Hereditary Hypophosphatemic Rickets with Hypercalciuria

    Valadares LP, de Carvalho DR

    Journal of clinical research in pediatric endocrinology 2025; (17(3)):326-331 doi:10.4274/jcrpe.galenos.2023.2023-5-2.

    PMID: 37680384
  4. 4

    Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) Presenting with Genu Valgum Deformity: Treatment with Phosphate Supplementation and Surgical Correction.

    Colazo JM, Reasoner SA, Holt G, et al.

    Case reports in endocrinology 2020; (2020()):1047327 doi:10.1155/2020/1047327.

    PMID: 32695531
  5. 5

    SLC34A3 Intronic Deletion in an Iranian Kindred with Hereditary Hypophosphatemic Rickets with Hypercalciuria

    Hasani-Ranjbar S, Ejtahed HS, Amoli MM, et al.

    Journal of clinical research in pediatric endocrinology 2018; (10(4)):343-349 doi:10.4274/jcrpe.0057.

    PMID: 29809158
  6. 6

    Late diagnosis of SLC34A3-related hereditary hypophosphatemic osteomalacia following a low-energy proximal humeral 4-part fracture.

    Morimoto T

    JBMR plus 2026; (10(10)):ziag137 doi:10.1093/jbmrpl/ziag137.

    PMID: 42741772
  7. 7

    Hereditary Hypophosphatemic Rickets with Hypercalciuria Presenting with Enthesopathy, Renal Cysts, and High Serum c-Terminal FGF23: Single-Center Experience and Systematic Review.

    Dodamani MH, Memon SS, Karlekar M, et al.

    Calcified tissue international 2024; (114(2)):137-146 doi:10.1007/s00223-023-01156-2.

    PMID: 37981601
  8. 8

    Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c.

    Brunkhorst M, Brunkhorst L, Martens H, et al.

    Kidney international 2025; (107(1)):116-129 doi:10.1016/j.kint.2024.08.035.

    PMID: 39461557
  9. 9

    Hereditary hypophosphatemic rickets with hypercalciuria: pathophysiology, clinical presentation, diagnosis and therapy.

    Bergwitz C, Miyamoto KI

    Pflugers Archiv : European journal of physiology 2019; (471(1)):149-163 doi:10.1007/s00424-018-2184-2.

    PMID: 30109410
  10. 10

    Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic <italic>SLC34A3</italic> and Monoallelic <italic>SLC3A1</italic> Pathogenic Variants - Who Is "The Culprit"?

    Olarewaju BA, Sabrowsky S, Shurrab S, et al.

    Kidney & blood pressure research 2026; (51(1)):280-284 doi:10.1159/000551270.

    PMID: 41849633
  11. 11

    An update on clinical presentation and responses to therapy of patients with hereditary hypophosphatemic rickets with hypercalciuria (HHRH).

    Zhu Z, Bo-Ran Ho B, Chen A, et al.

    Kidney international 2024; (105(5)):1058-1076 doi:10.1016/j.kint.2024.01.031.

    PMID: 38364990
  12. 12

    Clinical Spectrum of Hereditary Hypophosphatemic Rickets With Hypercalciuria (HHRH).

    Stürznickel J, Heider F, Delsmann A, et al.

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022; (37(8)):1580-1591 doi:10.1002/jbmr.4630.

    PMID: 35689455

This page is for informational purposes about HHRH symptoms and does not constitute medical advice. A nephrologist, genetic counselor, or other healthcare professional can interpret your findings and recommend appropriate screening.